Logo

Caprion

Saama-Led Consortium Seeks Data-Driven Answers to COVID-19

The newly launched EndPandemic National Data Consortium brings together seven life sciences and bioinformatics firms in search of treatments and vaccines.

Caprion, HistoGeneX Combining to Form New Firm

The new company, whose name was not disclosed, will provide preclinical and clinical immune monitoring and biomarker services to biopharma companies.

Caprion Biosciences Buys Immune Monitoring Firm Serametrix

Caprion said that the acquisition helps it acquire expertise in the analysis of myeloid-derived suppressor cells and expand its geographic coverage.

Roche Partners with Biognosys, Caprion to Demonstrate Proteomics Readiness for Clinical Trials
Premium

Roche ran a mock clinical trial in which it used DIA mass spec and targeted proteomics to profile 30 colorectal cancer samples under GCP conditions.

Caprion Acquires Primity Bio

According to Caprion, the company plans to use Primity's assets to expand its existing immunology and molecular profiling business.

Aug 24, 2017

Caprion Collaborating With FNIH to Test Alzheimer's Protein Panel
Premium

Aug 23, 2017

Caprion Collaborating with FNIH on Alzheimer's Biomarkers

Sep 15, 2016

Caprion Aims to Expand Immune Monitoring Business With European Acquisition
Premium

Sep 13, 2016

Caprion Acquires ImmuneHealth's Immune Monitoring Laboratory

Jul 22, 2016

Caprion Eyeing Acquisitions, Geographic Expansion After Purchase by GHO Capital
Premium

Jul 20, 2016

Caprion Acquired by GHO Capital

Feb 4, 2016

Results From Merck Collaboration Have Caprion Eyeing Clinical Role for ImmuneCarta Platform
Premium

Feb 5, 2015

Caprion Licenses Indi's Xpresys as Part of Larger Clinical Push
Premium

Feb 3, 2015

Caprion Takes Licenses to Indi's Xpresys Lung Test

Dec 31, 2014

Abcodia Taps Caprion's Mass Spec Proteomics Platforms for Cancer Biomarker Development
Premium

Dec 10, 2014

Additional Members Join UK Cancer Consortium

Oct 18, 2013

InDi Publishes Discovery, Validation Data Underpinning Forthcoming Proteomic Lung Cancer Dx
Premium

Feb 22, 2013

Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project
Premium

Feb 15, 2013

Quebec Launches $21M Personalized Medicine Partnership

Jan 4, 2013

2012 Sees Rise of Targeted Proteomics and DIA-MS, Continued Clinical Push by Big Industry Players
Premium

Dec 14, 2012

Myriad RBM Collaborating with Sanofi on Protein Biomarkers for Diabetes Diagnosis, Drug Response
Premium

Jul 27, 2012

MRM-MS 'Core' to Caprion's Protein Dx Strategy in Wake of Acquisition by Chicago Growth Partners
Premium

Jul 19, 2012

Thallion Sells Stake in Caprion for $4.5M

Oct 22, 2010

Caprion Identifies Protein Biomarkers for Predicting Patient Response to New Hepatitis C Drug
Premium

Jan 22, 2010

Caprion Buys PPD's Biomarker Business